Be Aware of What’s Behind a Pharma Mobile App: Disclaimers Only Tell Part of...
Some time ago, I pointed out that certain mobile apps developed by pharmaceutical companies for use by physicians lack adequate disclaimers. Specifically, I was...
Gov’t SoMo Media Aimed at Teen Smokers: We’re Not Telling You What to Do
I just learned that the National Cancer Institute (NCI) has launched a Mobile phone app ("SmokefreeTXT") and a social media campaign designed to help...
Is the Pharma Industry Responsible for FDA’s Delay in Issuing Social Media Guidelines?
I just read an interesting MM&M piece about how measures to curb the deficit might impact the pharmaceutical industry (see "Pharma Marketing Outlook 2012:...
Pharma Paid Celebrity Best Practices
Pharma Paid Celebrity Best Practices Should Pharma Disclose Payments to Celebrity Spokespeople?Pharma marketers in the U.S. sometimes...
Are Pharma Sales Reps Service Employees?
The Supreme Court has agreed to decide whether drug companies have to pay their sales representatives for working overtime hours, a question that could have considerable financial impact on the industry. The question before the court in case CHRISTOPHER V. SMITHKLINE BEECHAM CORP is whether or not pharmaceutical sales representatives are exempt from overtime pay under the 'outside sales' exemption of the Fair Labor Standards Act of 1938. If the Supreme Court rules that pharma sales reps are NOT exempt, some sales reps worry that they will become
Deconstructing Pitts’ Guiding Principles for Pharma Social Media
Peter Pitts, author of DrugWonks Blog, has put together 11
Pfizer Battles to Protect Lipitor Cash Cow
Lipitor Won't Go Gentle Into that Good Generic Night. Pfizer is taking a number of steps to protect it's Lipitor franchise and it hopes that many patients currently taking Lipitor will remain loyal to the brand.
Limiting Bias in Commercially Supported CME
Many critics of pharma-supported CME believe this support leads to bias. Between 9 May 2011 and 13 September 2011, readers of Pharma Marketing News were asked to answer a few short questions relating to potential bias in industry-supported CME programs and how to limit the need for industry funding of CME. The results are summarized in this article.
Limiting Bias in Commercially Supported CME
Many critics of pharma-supported CME believe this support leads to bias. Between 9 May 2011 and 13 September 2011, readers of Pharma Marketing News were asked to answer a few short questions relating to potential bias in industry-supported CME programs and how to limit the need for industry funding of CME. The results are summarized in this article.
The Changing Pharma eDetailing Landscape
A conversation with Monique Levy, VP Research at Manhattan Research, about the changing pharma eDetailing landscape. Ms. Levy discusses how the online pharma promotion landscape has changed, and which types of programs garner the largest audience as well as how the rep relationship is evolving and the role of new technologies such as tablets.
